Amide Technologies
Latest round
- Series A
Last raised
- Jul 2023
Total raised
- $17M
Investors
- 3
About Amide Technologies
, operates as a biotechnology company that develops technologies to improve the manufacturing process of complex peptides. In December 2023, Amide Technologies, Inc. The company offers an automated fast-flow peptide synthesizer uses heat and flow to allow for the quick and efficient synthesis of highly hydrophobic peptides, cyclic constructs, branched peptides, and mirror image proteins. The company’s technology enables novel modalities to provide enhanced stability against enzymatic degradation.
Who invested in Amide Technologies
3 investors across 2 rounds
See all investors in Amide Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Amide Technologies
Who invested in Amide Technologies?
Amide Technologies has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Amide Technologies raised?
Amide Technologies has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Amide Technologies last raise money?
Amide Technologies's most recent round on record is a Series A, in Jul 2023.
What does Amide Technologies do?
, operates as a biotechnology company that develops technologies to improve the manufacturing process of complex peptides.
Where is Amide Technologies headquartered?
Amide Technologies is headquartered in Cambridge, US.
Which VCs invest in companies like Amide Technologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Amide Technologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Amide Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.